KC
NDRM

Kellner Capital’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Kellner Capital’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-65,600
Closed -$2.55M – 43
2017
Q3 		$2.55M Buy
+65,600
New +$2.41M 1.72% 18

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Kellner Capital's NDRM Position: Q4 2017 in Review

Kellner Capital sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 65,600 shares — an estimated $2.55M sold.

Kellner Capital first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $2.55M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Kellner Capital reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Kellner Capital sold 65,600 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $2.55M.
  • Kellner Capital first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Kellner Capital's NeuroDerm Ltd. Ordinary Shares position peaked at $2.55M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Kellner Capital's 13F filing for Q4 2017, filed 12 Feb 2018.